| 영문 | antacid | 한글 | 제산제 |
|---|---|---|---|
| 설명 | 위산은 아주 강력한 산이라서 보통의 조직은 모두 손상을 받을 수 밖에 없다. 하지만 위산의 영향을 직접받는 위의 점막은 특수한 메커니즘으로 인하여 위산으로 부터 보호를 받는다. 하지만 위산의 분비가 너무나 과도하던지 혹은 위점막의 보호를 하는 특수한 메커니즘이 약해지게 되면 위점막이 위산으로 인해서 손상을 받게 되다. 이렇게 위산과 위점막의 방어메커니즘이 평형을 이루지 못해서 위점막이 손상을 받는 것이 위궤양이다. 제산제란 위산을 중화할 수 있는 물질로써 위산의 산도를 나추며 위궤양의 치료에 쓰인다. |
||
| 영문 | calcium | 한글 | 칼슘 |
|---|---|---|---|
| 설명 | 신체의 거의 모든 조직에서 발견되는 전해질로 여러 가지 역할을 몸에서 담당한다. 중요한 기능을 살펴보면 우선 인산과 결합하여 뼈나 이빨을 만드는 역할을 한다. 그리고 모든 근육의 수축에 없어서는 안될 전해질로 작용을 한다. 혈액응고의 여러 단계에도 관여한다. |
||
| AAOC | antacid of choice |
|---|---|
| Tabs | tablets |
| HBUS | Hepato-Biliary Ultra-Sound |
| PUVA | Psoralen & Ultra Violet A |
| SCUF | Slow Continous Ultra-Filtration |
| CICR | Calcium Induced Calcium Release |
|---|---|
| PUVA | Psoralen-ultra violet A |
| TRUS | Trans-rectal ultra-sonography |
| UHMWPE | Ultra high molecular weight polyethylene |
| UHT | Ultra high temperature |
ultrabrachycephalic : 초단두의 두개 지수가 90% 이상인 상태.
ultracentrafuge
| antacid | <pharmacology> A substance that counteracts or neutralises acidity, usually of the stomach. Origin: L. Acidus = sour (16 Dec 1997) |
|---|---|
| ultra- | Excess, exaggeration, beyond. Origin: L. Beyond (05 Mar 2000) |
| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
| benzoylpas calcium | 4-Benzamidosalicylic acid calcium salt;an antituberculous agent. (05 Mar 2000) |
| calcium | <element> An element taken in through the diet that is essential for a variety of bodily functions, such as neurotransmission, muscle contraction and proper heart function. Imbalances of calcium can lead to many health problems and excess calcium in nerve cells can cause their death. (22 May 1997) |
| calcium-45 | <radiobiology> Most easily available of the radioactive calcium-45 isotopes; beta-emitter with a half-life of 162.7 days; used as a tracer. (05 Mar 2000) |
| calcium-47 | <radiobiology> A radioisotope of calcium with a half-life of 4.54 days, used in the diagnosis of disorders of calcium metabolism. (05 Mar 2000) |
| calcium alginate | A topical haemostatic. (05 Mar 2000) |
| calcium aminosalicylate | The calcium salt of p-aminosalicylic acid, with the same uses. (05 Mar 2000) |
| calcium antagonist | calcium channel-blocking agent |
| calcium ATPase | <enzyme> Usually used of the calcium pumping ATPase present in high concentration as an integral membrane protein of the sarcoplasmic reticulum of muscle. This pump lowers the cytoplasmic calcium level and causes contraction to stop. Normal function of the pump seems to require a local phospholipid environment from which cholesterol is excluded. (18 Nov 1997) |
| calcium benzoylpas | Calcium 4-benzamidosalicylate;an antituberculous agent. (05 Mar 2000) |
| calcium-binding protein | <biochemistry> There are two main groups of calcium binding proteins, those that are similar to calmodulin and are called EF hand proteins and those that bind calcium and phospholipid (e.g. Lipocortin) and that have been grouped under the generic name of annexins. Many other proteins will bind calcium, although the binding site usually has considerable homology with the calcium-binding domains of calmodulin. They can act as transport proteins, regulator proteins or activator proteins. There is also a vitamin D-dependent variant which is a protein that plays a fundamental role in the vitamin d mediated transport of calcium in reptiles, amphibians, birds and mammals. It is found in the intestine, kidneys, egg shell gland, brain, and possibly other organs. Its molecular weight is species dependent. (12 May 2002) |
| calcium bromide | Used to meet the same indications as potassium bromide. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|